- Home
- FBIOP vs TECH Comparison
FBIOP vs TECH Comparison
Compare FBIOP & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- TECH
- Stock Information
- Founded
- FBIOP N/A
- TECH 1976
- Country
- FBIOP United States
- TECH United States
- Employees
- FBIOP 186
- TECH N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBIOP Health Care
- TECH Health Care
- Exchange
- FBIOP Nasdaq
- TECH Nasdaq
- Market Cap
- FBIOP N/A
- TECH N/A
- IPO Year
- FBIOP N/A
- TECH 1989
- Fundamental
- Price
- FBIOP $5.75
- TECH $58.38
- Analyst Decision
- FBIOP
- TECH Buy
- Analyst Count
- FBIOP 0
- TECH 8
- Target Price
- FBIOP N/A
- TECH $81.25
- AVG Volume (30 Days)
- FBIOP N/A
- TECH 1.9M
- Earning Date
- FBIOP N/A
- TECH 04-30-2025
- Dividend Yield
- FBIOP N/A
- TECH 0.55%
- EPS Growth
- FBIOP N/A
- TECH N/A
- EPS
- FBIOP N/A
- TECH 0.98
- Revenue
- FBIOP N/A
- TECH $1,196,016,000.00
- Revenue This Year
- FBIOP N/A
- TECH $8.28
- Revenue Next Year
- FBIOP N/A
- TECH $8.92
- P/E Ratio
- FBIOP N/A
- TECH $58.54
- Revenue Growth
- FBIOP N/A
- TECH 4.46
- 52 Week Low
- FBIOP N/A
- TECH $56.60
- 52 Week High
- FBIOP N/A
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- FBIOP 35.47
- TECH 37.87
- Support Level
- FBIOP $5.50
- TECH $56.70
- Resistance Level
- FBIOP $6.74
- TECH $60.79
- Average True Range (ATR)
- FBIOP 0.27
- TECH 1.87
- MACD
- FBIOP -0.08
- TECH 0.02
- Stochastic Oscillator
- FBIOP 20.00
- TECH 23.80
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.